Kronos Bio, Inc. Profile Avatar - Palmy Investing

Kronos Bio, Inc.

Kronos Bio, Inc., a clinical-stage biopharmaceutical company, focuses on the discovery and development of novel cancer therapeutics. The company's product engine focuses on dysregulated transcription factors and the transcriptional regulatory networks th…

Biotechnology
US, San Mateo [HQ]

Document Reader

Click To Read:

DEF 14-A Proxies

Not a single DEF 14-A proxy doc.

10-K Filings

Not a single 10-K doc.

10-Q Filings

Not a single 10-Q doc.

LDA 1/2 Filings [Lobbying]

Not a single LDA doc.

End of KRON's Analysis
CIK: 1741830 CUSIP: 50107A104 ISIN: US50107A1043 LEI: - UEI: -
Secondary Listings
KRON has no secondary listings inside our databases.